2m 2m 2m 2m 2m 2m 2m
ADAPTIVE BIOTECH (ADPT)
NASDAQ
$17.45+$0.07 (+0.43%)
Price as of Jun 23, 2026 3:18 PM EDT- $2.8BMarket Cap
- 64.49%1-Year Change
- Diagnostics & ResearchIndustry
ADAPTIVE BIOTECH (ADPT)
$17.45+$0.07 (+0.43%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 277.0M +54.77% | 179.0M +5.10% | 170.3M -8.11% | 185.3M +20.06% | |
Cost of Revenue | 71.4M -1.00% | 72.1M -4.60% | 75.6M +30.47% | 57.9M +17.46% | |
Gross Profit | 205.6M +92.39% | 106.9M +12.83% | 94.7M -25.65% | 127.4M +21.28% | |
Sales and Marketing Expense | 94.6M +11.58% | 84.8M -4.31% | 88.6M -7.35% | 95.6M +0.14% | |
Research and Development Expense | -93.8M -8.92% | -103.0M -15.69% | -122.1M -13.85% | -141.8M -0.41% | |
Depreciation and Amortization Expense | 1.7M -0.23% | 1.7M +0.24% | 1.7M 0.00% | 1.7M 0.00% | |
Total Operating Expenses | 334.1M -2.17% | 341.5M -14.05% | 397.3M +3.07% | 385.5M +6.11% | |
Operating Profit | -57.1M -64.86% | -162.5M -28.40% | -227.0M +13.41% | -200.2M -4.20% | |
Interest Income | 9.4M -35.02% | 14.5M -6.42% | 15.5M +282.91% | 4.1M +143.17% | |
Interest Expense | -11.8M +1.71% | -11.6M -16.09% | -13.8M +225.63% | -4.2M N/A | |
Interest Income and Expense and Net | -2.3M -179.01% | 3.0M +70.65% | 1.7M +1,051.10% | -182,000 -110.91% | |
Total Nonoperating Income and Expense | 11.8M +1.71% | 11.6M -16.09% | 13.8M +225.63% | 4.2M N/A | |
Income before Taxes | -57.1M -64.86% | -162.5M -28.40% | -227.0M +13.41% | -200.2M -3.42% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | 7.2M N/A | N/A N/A | N/A N/A | |
Net Income | -59.5M -62.69% | -159.5M -29.19% | -225.3M +12.52% | -200.2M -3.42% | |
Net Income from Continuing Operations Applicable to Common | -59.5M -62.69% | -159.5M -29.19% | -225.3M +12.52% | -200.2M -3.42% | |
Basic EPS and Net Income | -0.39 -63.89% | -1.08 -30.77% | -1.56 +11.43% | -1.40 -5.41% | |
Diluted EPS and Net Income | -0.39 -63.89% | -1.08 -30.77% | -1.56 +11.43% | -1.40 -5.41% | |
Basic Weighted Average Shares | 151.7M +3.14% | 147.1M +1.88% | 144.4M +1.31% | 142.5M +1.54% | |
Diluted Weighted Average Shares | 151.7M +3.14% | 147.1M +1.88% | 144.4M +1.31% | 142.5M +1.54% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 70.5M +47.11% | 47.9M -26.35% | 65.1M -27.73% | 90.0M -35.26% | |
Short-Term Investments | 156.5M -10.26% | 174.4M -38.02% | 281.3M -31.07% | 408.2M +90.74% | |
Cash and Cash Equivalents and Short-Term Investments | 227.0M +2.11% | 222.3M -35.83% | 346.4M -30.47% | 498.2M +41.11% | |
Total Current Assets | 300.2M +5.79% | 283.8M -30.82% | 410.2M -27.03% | 562.1M +39.58% | |
Accumulated Depreciation | 95.8M +9.07% | 87.8M +19.91% | 73.2M +34.75% | 54.4M +50.03% | |
Property and Plant and Equipment and Net | 34.1M -29.84% | 48.6M -28.74% | 68.2M -18.24% | 83.4M -2.13% | |
Total Long-Term Assets | 1.2M -47.22% | 2.3M -36.31% | 3.6M +73.98% | 2.1M +135.89% | |
Total Assets | 512.7M -4.94% | 539.4M -18.42% | 661.1M -22.82% | 856.6M -7.23% | |
Income Taxes Payable | 541,000 +207.39% | 176,000 +198.31% | 59,000 -69.59% | 194,000 -50.38% | |
Total Short-Term Debt | 4.6M +436.65% | 865,000 N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 89.9M -8.30% | 98.1M +11.40% | 88.0M -19.83% | 109.8M -3.53% | |
Total Long-Term Debt | 126.6M -4.42% | 132.4M +1.34% | 130.7M N/A | N/A N/A | |
Total Long-Term Liabilities | 20,000 0.00% | 20,000 -99.99% | 264.8M +68.29% | 157.4M -23.40% | |
Total Liabilities | 287.7M -14.59% | 336.9M -4.52% | 352.9M -10.10% | 392.5M +22.95% | |
Retained Earnings | -1.4B +4.56% | -1.3B +13.94% | -1.1B +24.51% | -919.1M +27.85% | |
Total Stockholders Equity | 218.8M +7.93% | 202.7M -34.27% | 308.4M -33.56% | 464.2M -23.15% | |
Total Shares Outstanding | 153.8M +4.06% | 147.8M +1.86% | 145.1M +1.38% | 143.1M +1.21% | |
Cash Flow | |||||
Cash from Operating Activities | -46.0M -51.70% | -95.2M -39.09% | -156.3M -15.02% | -183.9M -4.56% | |
Capital Expenditures | 3.0M -19.24% | 3.7M -65.75% | 10.7M -34.57% | 16.3M -73.52% | |
Cash from Investing Activities | 38.0M -51.22% | 77.8M -40.00% | 129.6M +4,362.89% | 2.9M -98.40% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 30.4M +12,515.35% | 241,000 -89.27% | 2.2M -98.30% | 132.3M +387.24% | |
Financials Ratio | |||||
Gross Margin | 74.24% +24.30% | 59.72% +7.36% | 55.63% -19.08% | 68.75% +1.02% | |
Operating Margin | -20.62% -77.29% | -90.83% -31.88% | -133.33% +23.42% | -108.03% -20.21% | |
Return on Assets | -11.31% -57.43% | -26.57% -10.48% | -29.68% +31.96% | -22.49% +10.68% | |
Return on Equity | -28.23% -54.76% | -62.41% +7.03% | -58.31% +55.57% | -37.48% +21.82% | |
Revenue Growth | 54.77% +974.35% | 5.10% +162.85% | -8.11% -140.43% | 20.06% -64.73% | |
Current Ratio | 3.34 +15.36% | 2.89 -37.90% | 4.66 -8.98% | 5.12 +44.69% | |
Cash Ratio | 0.78 +60.43% | 0.49 -33.89% | 0.74 -9.85% | 0.82 -32.89% | |
Debt-to-Equity Ratio | 0.60 -8.79% | 0.66 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.26 +3.56% | 0.25 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow